13F filer · CIK 1697748 ↗
ARK Invest
You are looking at Q2 2020. See the latest, Q2 2026 →
Reported value
$9.30B
+132% on the quarter before
Positions
213
16 new · 10 sold out
Top 10
48.5%
of the value
Est. gain
+$2.32B
on stocks held all quarter
Est. return
+59.8%
on those stocks since Q1 2020
Positions as of Jun 30, 2020, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2020. Striped tiles are options.
Largest buys
Since Q1 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Invitae Corp~$234.0MAdded · 5.5% → 7.8%+7,725,962 shares
- Roku Inc~$190.7MAdded · 3.7% → 4.2%+1,636,130 shares
- Crispr Therapeutics Ag~$161.5MAdded · 4.5% → 5.1%+2,197,619 shares
- Slack Technologies Inc~$147.0MNew · 0.0% → 1.6%+4,728,097 shares
- Lendingtree Inc~$134.6MAdded · 2.2% → 2.9%+465,009 shares
- Block~$131.9MAdded · 6.2% → 6.8%+1,256,887 shares
- Tesla~$124.9MAdded · 7.8% → 8.3%+115,699 shares
- Everpure~$117.8MAdded · 1.3% → 2.1%+6,794,985 shares
- 2u Inc~$108.8MAdded · 3.6% → 3.9%+2,865,194 shares
- Zillow Group Inc~$96.8MAdded · 2.8% → 3.1%+1,684,211 shares
Largest sells
Since Q1 2020, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$37.3MCut · 1.0% → 0.2%−98,112 shares
- Twitter Inc~$28.9MCut · 0.9% → 0.1%−970,655 shares
- Illumina Inc~$28.0MCut · 6.8% → 3.7%−75,489 shares
- Autodesk~$23.5MCut · 1.7% → 0.9%−98,050 shares
- Inovio Pharmaceuticals Inc~$23.4MCut · 0.3% → 0.2%−866,499 shares
- AeroVironment~$18.4MCut · 0.6% → 0.1%−231,109 shares
- Lendingclub Corp~$8.1MCut · 1.1% → 0.2%−1,772,600 shares
- Twilio~$5.2MCut · 0.3% → 0.3%−23,830 shares
- Aptiv Plc~$4.1MCut · 0.1% → 0.0%−53,235 shares
- Alphabet~$1.6MSold out · 0.0% → 0.0%−1,352 shares
Holdings
As of Jun 30, 2020. Changes are in shares against Mar 31, 2020, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TeslaCommon Stock · shares +19% · price +106.1% | 8.3% | $769.2M | +$331.6M | ||||||||
| Invitae CorpCommon Stock · shares +48% · price +121.6% | 7.8% | $721.5M | +$267.5M | ||||||||
| BlockCommon Stock · shares +26% · price +100.3% | 6.8% | $633.4M | +$251.2M | ||||||||
| Crispr Therapeutics AgCommon Stock · shares +51% · price +73.3% | 5.1% | $476.5M | +$133.2M | ||||||||
| Roku IncCommon Stock · shares +97% · price +33.2% | 4.2% | $387.2M | +$49.0M | ||||||||
| 2u IncCommon Stock · shares +42% · price +78.9% | 3.9% | $365.3M | +$113.1M | ||||||||
| Illumina IncCommon Stock · shares −7.5% · price +35.6% | 3.7% | $343.9M | +$90.3M | ||||||||
| Zillow Group IncCommon Stock · shares +50% · price +69.2% | 3.1% | $289.3M | +$78.7M | ||||||||
| Lendingtree IncCommon Stock · shares +98% · price +57.9% | 2.9% | $272.4M | +$50.5M | ||||||||
| Proto Labs IncCommon Stock · shares +38% · price +47.7% | 2.7% | $249.3M | +$58.2M | ||||||||
| Intellia Therapeutics IncCommon Stock · shares +11% · price +71.9% | 2.6% | $239.7M | +$90.0M | ||||||||
| Editas Medicine IncCommon Stock · shares +41% · price +49.2% | 2.4% | $223.2M | +$52.0M | ||||||||
| Compugen LtdCommon Stock · shares +37% · price +106.9% | 2.3% | $211.8M | +$80.1M | ||||||||
| Xilinx IncCommon Stock · shares +35% · price +26.2% | 2.2% | $205.6M | +$31.7M | ||||||||
| Splunk IncCommon Stock · shares +30% · price +57.4% | 2.1% | $194.8M | +$54.7M | ||||||||
| EverpureCommon Stock · shares +157% · price +40.9% | 2.1% | $192.6M | +$21.7M | ||||||||
| Stratasys LtdCommon Stock · shares +15% · price −0.6% | 1.9% | $179.1M | −$881,226 | ||||||||
| Pinterest IncCommon Stock · shares +35% · price +43.6% | 1.8% | $167.7M | +$37.7M | ||||||||
| Pagerduty IncCommon Stock · shares +99% · price +65.6% | 1.6% | $148.8M | +$29.6M | ||||||||
| TeradyneCommon Stock · shares +143% · price +56.0% | 1.6% | $148.2M | +$21.9M | ||||||||
| Slack Technologies IncCommon Stock · shares New | 1.6% | $147.0M | — | ||||||||
| Cerus CorpCommon Stock · shares +55% · price +41.9% | 1.5% | $143.6M | +$27.3M | ||||||||
| Veracyte IncCommon Stock · shares +55% · price +6.5% | 1.4% | $131.2M | +$5.2M | ||||||||
| Iovance Biotherapeutics IncCommon Stock · shares +377% · price −8.3% | 1.3% | $116.3M | −$2.2M | ||||||||
| Materialise NvADR · shares +41% · price +21.5% | 1.2% | $107.4M | +$13.5M | ||||||||
| Total · 213 positions | 100% | $9.30B | +$2.32B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2020 to Q2 2020: 196 stocks held throughout, up $2.32B (+59.8%).
- Tesla+$331.6M+106%
- Invitae Corp+$267.5M+122%
- Block+$251.2M+100%
- Crispr Therapeutics Ag+$133.2M+73%
- 2u Inc+$113.1M+79%
- Wirecard Ag−$139,432−93%
- Cellular Biomedicine Group Inc−$339,340−5%
- Stratasys Ltd−$881,226−1%
- Iovance Biotherapeutics Inc−$2.2M−8%
- Lendingclub Corp−$12.3M−42%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $15.40B+20% | SEC ↗ |
| Q1 2026 | May 12, 2026 | $12.86B−15% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $15.07B−10% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $16.80B+23% | SEC ↗ |
| Q2 2025 | Jul 30, 2025 | $13.64B+37% | SEC ↗ |
| Q1 2025 | May 7, 2025 | $9.99B−17% | SEC ↗ |
| Q4 2024 | Feb 4, 2025 | $12.01B+10% | SEC ↗ |
| Q3 2024 | Oct 31, 2024 | $10.93B−3% | SEC ↗ |
| Q2 2024 | Jul 26, 2024 | $11.27B−22% | SEC ↗ |
| Q1 2024 | Apr 18, 2024 | $14.44B−14% | SEC ↗ |
| Q4 2023 | Jan 17, 2024 | $16.89B+29% | SEC ↗ |
| Q3 2023 | Oct 18, 2023 | $13.07B−13% | SEC ↗ |
| Q2 2023 | Jul 10, 2023 | $15.10B+4% | SEC ↗ |
| Q1 2023 | Apr 17, 2023 | $14.55B+26% | SEC ↗ |
| Q4 2022 | Jan 24, 2023 | $11.54B−20% | SEC ↗ |
| Q3 2022 | Oct 17, 2022 | $14.35B−15% | SEC ↗ |
| Q2 2022 | Jul 11, 2022 | $16.91B−29% | SEC ↗ |
| Q1 2022 | Apr 18, 2022 | $23.96B−28% | SEC ↗ |
| Q4 2021 | Jan 28, 2022 | $33.08B−21% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $41.64B−23% | SEC ↗ |
| Q2 2021 | Aug 5, 2021 | $53.74B+7% | SEC ↗ |
| Q1 2021 | May 13, 2021 | $50.34B+34% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $37.59B+123% | SEC ↗ |
| Q3 2020 | Oct 30, 2020 | $16.86B+81% | SEC ↗ |
| Q2 2020 | Aug 11, 2020 | $9.30B+132% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $4.01B+1% | SEC ↗ |
| Q4 2019 | Jan 31, 2020 | $3.96B−13% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $4.58B+15% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $3.97B+13% | SEC ↗ |
| Q1 2019 | May 13, 2019 | $3.50B+42% | SEC ↗ |
| Q4 2018 | Feb 11, 2019 (amended) | $2.46B−26% | SEC ↗ |
| Q3 2018 | Nov 7, 2018 | $3.31B+21% | SEC ↗ |
| Q2 2018 | Aug 7, 2018 | $2.73B+36% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $2.01B+60% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $1.26B+53% | SEC ↗ |
| Q3 2017 | Nov 9, 2017 | $819.3M+60% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $513.6M+48% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $346.9M+26% | SEC ↗ |
| Q4 2016 | Feb 13, 2017 | $274.9M | SEC ↗ |